Detalhe da pesquisa
1.
Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
J Med Virol
; 96(3): e29541, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516779
2.
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
J Infect Dis
; 226(12): 2129-2136, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576581
3.
De-implementation of Axillary Dissection in Women With Breast Cancer is Largely Driven By Site-level Contextual Effects.
Ann Surg
; 276(6): e923-e931, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351462
4.
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
BMC Infect Dis
; 22(1): 818, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344927
5.
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.
Lancet Reg Health Am
; 31: 100693, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500962
6.
Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.
Lancet Infect Dis
; 23(6): 696-705, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780912
7.
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase.
Int J Infect Dis
; 128: 310-317, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229005
8.
Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5.
Int J Infect Dis
; 132: 34-39, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072054
9.
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
Chest
; 163(5): 1061-1070, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441040
10.
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
medRxiv
; 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411339
11.
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
medRxiv
; 2022 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043117